Teachers Advisors LLC boosted its stake in shares of Alere Inc. (NYSE:ALR) by 13.2% during the first quarter, according to its most recent filing with the SEC. The firm owned 131,108 shares of the medical research company’s stock after buying an additional 15,245 shares during the period. Teachers Advisors LLC’s holdings in Alere were worth $5,209,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of ALR. Airain ltd boosted its position in Alere by 71.8% in the first quarter. Airain ltd now owns 28,828 shares of the medical research company’s stock valued at $1,145,000 after buying an additional 12,050 shares in the last quarter. Parametric Portfolio Associates LLC boosted its position in Alere by 7.5% in the first quarter. Parametric Portfolio Associates LLC now owns 85,861 shares of the medical research company’s stock valued at $3,411,000 after buying an additional 6,002 shares in the last quarter. Renaissance Technologies LLC purchased a new position in Alere during the fourth quarter valued at about $2,962,000. Asset Management One Co. Ltd. boosted its position in Alere by 0.5% in the first quarter. Asset Management One Co. Ltd. now owns 15,940 shares of the medical research company’s stock valued at $633,000 after buying an additional 79 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its position in Alere by 0.7% in the first quarter. Bank of New York Mellon Corp now owns 391,002 shares of the medical research company’s stock valued at $15,535,000 after buying an additional 2,583 shares in the last quarter. Institutional investors and hedge funds own 90.80% of the company’s stock.

Alere Inc. (NYSE:ALR) opened at 49.69 on Friday. Alere Inc. has a 12-month low of $34.41 and a 12-month high of $50.63. The company’s market cap is $4.34 billion. The stock’s 50 day moving average price is $50.29 and its 200 day moving average price is $44.91.

COPYRIGHT VIOLATION NOTICE: “Teachers Advisors LLC Purchases 15,245 Shares of Alere Inc. (ALR)” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another website, it was illegally copied and republished in violation of international trademark and copyright laws. The original version of this article can be read at https://www.thecerbatgem.com/2017/08/04/teachers-advisors-llc-purchases-15245-shares-of-alere-inc-alr.html.

Several equities analysts recently issued reports on ALR shares. BidaskClub cut Alere from a “buy” rating to a “hold” rating in a report on Sunday, July 16th. Canaccord Genuity restated a “buy” rating and set a $51.00 target price on shares of Alere in a report on Monday, May 22nd. Zacks Investment Research cut Alere from a “hold” rating to a “strong sell” rating in a report on Wednesday, April 19th. BTIG Research restated a “neutral” rating on shares of Alere in a report on Monday, May 15th. Finally, Jefferies Group LLC restated a “hold” rating and set a $51.00 target price on shares of Alere in a report on Thursday, June 1st. Seven research analysts have rated the stock with a hold rating, The company currently has an average rating of “Hold” and an average price target of $48.00.

Alere Company Profile

Alere Inc is a provider of health information through diagnostic tests. The Company’s segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus.

Want to see what other hedge funds are holding ALR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alere Inc. (NYSE:ALR).

Institutional Ownership by Quarter for Alere (NYSE:ALR)

Receive News & Stock Ratings for Alere Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alere Inc. and related stocks with our FREE daily email newsletter.